Hangzhou Tigermed Consulting Co Stock

Hangzhou Tigermed Consulting Co Dividend 2024

Hangzhou Tigermed Consulting Co Dividend

0.55 CNY

Hangzhou Tigermed Consulting Co Dividend yield

0.8 %

Ticker

300347.SZ

ISIN

CNE100001KV8

How much dividend does Hangzhou Tigermed Consulting Co 2024 pay?

According to the latest status from October 2024, Hangzhou Tigermed Consulting Co paid a total of 0.55 CNY per share in dividends within the last 12 months. With the current Hangzhou Tigermed Consulting Co price of 68.99 CNY, this corresponds to a dividend yield of 0.8 %. A dividend is paid times per year.

0.8 % Dividend Yield=
0.55 CNY Dividend
68.99 CNY Stock Price

Historical Hangzhou Tigermed Consulting Co Dividends

A dividend is paid times per year. Last year, the payout months were and August.

PaydateDividend
8/12/20240.57
8/7/20230.55
7/1/20220.5
7/1/20210.3
6/22/20200.28
8/1/20190.23
6/30/20180.2
10/19/20170.1
6/20/20160.1
6/20/20150.1
5/22/20140.2
6/2/20130.4
1

Hangzhou Tigermed Consulting Co dividend history and estimates

In 2023, Hangzhou Tigermed Consulting Co paid a dividend amounting to 0.55 CNY. Dividend means that Hangzhou Tigermed Consulting Co distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Hangzhou Tigermed Consulting Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Hangzhou Tigermed Consulting Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Hangzhou Tigermed Consulting Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Hangzhou Tigermed Consulting Co Dividend History

DateHangzhou Tigermed Consulting Co Dividend
2026e0.6 undefined
2025e0.6 undefined
2024e0.6 undefined
20230.55 undefined
20220.5 undefined
20210.3 undefined
20200.28 undefined
20190.23 undefined
20180.13 undefined
20170.07 undefined
20160.07 undefined
20150.07 undefined
20140.07 undefined
20130.07 undefined

Is the Hangzhou Tigermed Consulting Co Dividend Safe?

Hangzhou Tigermed Consulting Co has been increasing the dividend for 6 years.

Over the past 10 years, Hangzhou Tigermed Consulting Co has increased it by an annual 23.494 %.

Over a five-year period, the distribution increased by 32.765%.

Analysts expect a Dividend Increase of 4.262% for the current fiscal year.

Hangzhou Tigermed Consulting Co dividend payout ratio

In 2023, Hangzhou Tigermed Consulting Co had a payout ratio of 14.45%. The payout ratio indicates the percentage of the company's profits that Hangzhou Tigermed Consulting Co distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Hangzhou Tigermed Consulting Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Hangzhou Tigermed Consulting Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Hangzhou Tigermed Consulting Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Hangzhou Tigermed Consulting Co Payout Ratio History

DateHangzhou Tigermed Consulting Co Payout ratio
2026e15.49 %
2025e17.01 %
2024e15.03 %
202314.45 %
202221.55 %
20219.09 %
202012.69 %
201920.65 %
201821.16 %
201716.67 %
201633.33 %
201527.78 %
201433.33 %
201344.44 %
201214.45 %
201114.45 %
201014.45 %
200914.45 %

Dividend Details

Understanding Hangzhou Tigermed Consulting Co's Dividend Distributions

Hangzhou Tigermed Consulting Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Hangzhou Tigermed Consulting Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Hangzhou Tigermed Consulting Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Hangzhou Tigermed Consulting Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Hangzhou Tigermed Consulting Co Aktienanalyse

What does Hangzhou Tigermed Consulting Co do?

Hangzhou Tigermed Consulting Co Ltd is a leading Chinese company in the field of clinical research and medical services. The company was founded in Hangzhou in 2004 and has since experienced rapid development. Today, the company has branches in over 20 countries and employs over 11,000 people worldwide. Hangzhou Tigermed's business model is based on supporting the entire value chain of clinical trials, from planning and execution to statistical analysis and data interpretation. The company works closely with global actors from the pharmaceutical industry, biomedical research institutions, and regulatory authorities to meet international standards for clinical studies. Over the years, Hangzhou Tigermed has expanded its business activities to include various areas such as data management, biostatistics, medical translation, clinical monitoring, drug safety monitoring, and traceability. An important part of Hangzhou Tigermed's business model is the ability to use high-tech platforms and IT systems to enable real-time monitoring and communication during a clinical trial. This allows the company to quickly respond to adverse events and monitor the progress of the study in real-time. The company also offers specialized services, such as the evaluation of oncology studies and the conduct of studies in the field of traditional Chinese medicine. In addition, Hangzhou Tigermed also has its own pharmaceutical research department specializing in the development of innovative drugs. The company has built strong research and development capabilities, with a focus on open innovation projects and partnerships with research institutions and pharmaceutical companies. In collaboration with its industry partners, Hangzhou Tigermed has conducted a number of research projects that have led to significant innovations in medicine. Hangzhou Tigermed also has a strong presence in the international market, particularly in North America and Europe. Through its branches in these regions, the company is able to offer comprehensive collaboration to its customers on a global level. Overall, Hangzhou Tigermed Consulting Co Ltd has established itself as a significant force in the clinical research industry. The company has developed a wide range of services to meet the needs of its customers in the industry. Hangzhou Tigermed's ability to work closely with its customers and adhere to global standards has helped it become a preferred partner for clinical studies and innovative research projects worldwide. Hangzhou Tigermed Consulting Co is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Hangzhou Tigermed Consulting Co stock

How much dividend does Hangzhou Tigermed Consulting Co pay?

Over the past 12 months, Hangzhou Tigermed Consulting Co paid a dividend of 0.55 CNY . This corresponds to a dividend yield of about 0.8 %. For the coming 12 months, Hangzhou Tigermed Consulting Co is expected to pay a dividend of 0.6 CNY.

What is the dividend yield of Hangzhou Tigermed Consulting Co?

The current dividend yield of Hangzhou Tigermed Consulting Co is 0.8 %.

When does Hangzhou Tigermed Consulting Co pay dividends?

Hangzhou Tigermed Consulting Co pays a quarterly dividend. This is distributed in the months of July, June, August, August.

How secure is the dividend of Hangzhou Tigermed Consulting Co?

Hangzhou Tigermed Consulting Co paid dividends every year for the past 14 years.

What is the dividend of Hangzhou Tigermed Consulting Co?

For the upcoming 12 months, dividends amounting to 0.6 CNY are expected. This corresponds to a dividend yield of 0.87 %.

In which sector is Hangzhou Tigermed Consulting Co located?

Hangzhou Tigermed Consulting Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hangzhou Tigermed Consulting Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hangzhou Tigermed Consulting Co from 7/12/2024 amounting to 0.568 CNY, you needed to have the stock in your portfolio before the ex-date on 7/12/2024.

When did Hangzhou Tigermed Consulting Co pay the last dividend?

The last dividend was paid out on 7/12/2024.

What was the dividend of Hangzhou Tigermed Consulting Co in the year 2023?

In the year 2023, Hangzhou Tigermed Consulting Co distributed 0.5 CNY as dividends.

In which currency does Hangzhou Tigermed Consulting Co pay out the dividend?

The dividends of Hangzhou Tigermed Consulting Co are distributed in CNY.

Andere Kennzahlen von Hangzhou Tigermed Consulting Co

Our stock analysis for Hangzhou Tigermed Consulting Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hangzhou Tigermed Consulting Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.